Tender detail
Framework agreement for the development and synthesis of Liver X receptor ligands
Summary
The tender concerns a framework agreement for research services to develop and synthesise selective, well-tolerated and highly potent Liver X receptor (LXR) ligands. The work is intended to support the development of a potential pharmaceutical treatment for degenerative aortic valve stenosis. The submission deadline is 25 August 2026. Precise participation, compliance and qualification requirements must be checked in the official tender documents.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.